Hi Gav,
You kind of lost me half way through but all good,
It is fortunate we get a second shot at GvHD. There is Merit in that alone.
I am not quite sure (at this stage) that Silviu and Co. (new) provided Stellar Survival/Potency/QA data to satisfy the FDA. This is a question that only the FDA will answer.
We will not get a 3rd shot.
Something to mull over in the coming months.
Two G&T's in so feeling a bit tired with it all.
Cheers,
What.
MSB AGM - confidence restored, page-62
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |